Exin Therapeutics Chief Scientific Officer Ivan Lazarte (center) with officials of the Board of Investments (BOI photo)
Exin Therapeutics Inc., a biotech startup that harnesses artificial intelligence (AI) to expedite drug discovery, is planning to invest over ₱1 billion within the next four years as part of its expansion in the Philippines.
In a statement, the Board of Investments (BOI) said it has facilitated the swift entry and commencement of operations of Exin Therapeutics in the country through green lane certification.
Under Executive Order (EO) No
Continue Reading on Manila Bulletin
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.